Bio-Path Holdings Q1 2025: Net Loss of $1.7M
Ticker: BPTH · Form: 10-Q · Filed: May 15, 2025 · CIK: 1133818
| Field | Detail |
|---|---|
| Company | Bio-Path Holdings, Inc. (BPTH) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotech
TL;DR
Bio-Path Holdings lost $1.7M in Q1 2025, assets $7.06M, liabilities $0.65M.
AI Summary
Bio-Path Holdings, Inc. filed its quarterly report for the period ending March 31, 2025. The company reported total assets of $7.06 million and total liabilities of $0.65 million as of March 31, 2025. For the three months ended March 31, 2025, the company had a net loss of $1.7 million.
Why It Matters
This filing provides insight into Bio-Path Holdings' financial performance and operational status for the first quarter of 2025, which is crucial for investors assessing the company's viability and future prospects.
Risk Assessment
Risk Level: medium — The company reported a net loss, indicating ongoing financial challenges that could impact its long-term sustainability.
Key Numbers
- $7.06M — Total Assets (As of March 31, 2025)
- $0.65M — Total Liabilities (As of March 31, 2025)
- $1.7M — Net Loss (For the three months ended March 31, 2025)
Key Players & Entities
- BIO-PATH HOLDINGS, INC. (company) — Filer of the 10-Q report
- March 31, 2025 (date) — End of the reporting period
- $7.06 million (dollar_amount) — Total assets as of March 31, 2025
- $0.65 million (dollar_amount) — Total liabilities as of March 31, 2025
- $1.7 million (dollar_amount) — Net loss for the three months ended March 31, 2025
FAQ
What was Bio-Path Holdings' net loss for the first quarter of 2025?
Bio-Path Holdings reported a net loss of $1.7 million for the three months ended March 31, 2025.
What were the total assets of Bio-Path Holdings as of March 31, 2025?
As of March 31, 2025, Bio-Path Holdings had total assets of $7.06 million.
What were the total liabilities of Bio-Path Holdings as of March 31, 2025?
As of March 31, 2025, Bio-Path Holdings had total liabilities of $0.65 million.
What is the fiscal year end for Bio-Path Holdings?
The fiscal year end for Bio-Path Holdings is December 31.
What industry is Bio-Path Holdings classified under?
Bio-Path Holdings is classified under Pharmaceutical Preparations [2834].
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding BIO-PATH HOLDINGS, INC. (BPTH).